SCHEMBL22236774

SCHEMBL22236774

CC(C)NC(=O)CN1CCN(c2cncc(I)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ CHRM5 P08912 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ GFER P55789 1/20 0.43
▸ CYP11B2 P19099 7/20 0.43
▸ PTPN11 Q06124 1/20 0.43
▸ GAA P10253 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ UGT8 Q16880 2/20 0.41
▸ HPGD P15428 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ WNT1 P04628 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18791083 0.85 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL18790969 0.80 CYP11B2 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL18791007 0.79 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL18791006 0.75 CYP11B2 (0.42) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL18790986 0.75 CYP11B2 (0.65) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL12082132 0.75 GFER (0.57) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL12890282 0.75 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2TDP1KMT2A
SCHEMBL18791082 0.74 CYP11B2 (0.68) ALDH1A1KDM4ESMN1; SMN2TDP1MAPT
SCHEMBL23464917 0.73 CHRM5 (0.75) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5
SCHEMBL18790990 0.73 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2020-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound REN, NR3C2, NR5A1 ALDH1A1 1495/4885KDM4E 2819/4885SMN1; SMN2 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback